Search Results - theodoros+kelesidis

3 Results Sort By:
Nrf2 Agonist as Therapeutic Modality to Increase Antiviral Efficacy of Existing Antivirals Against Coronavirus Infections (UCLA Case No. 2022-325)
UCLA researchers in the School of Medicine’s department of Infectious Disease have identified a novel therapeutic approach that can supplement existing FDA approved treatments for SARS-CoV2-2 infections to provide robust treatments against morbidity. BACKGROUND: The World Health Organization reports that as of June 2023, there have been over...
Published: 2/23/2024   |   Inventor(s): Theodoros Kelesidis
Keywords(s): Coronavirus, COVID-19, Paxlovid, SARS-CoV-2, Viral Medication
Category(s): Therapeutics > Infectious Diseases
2021-272: APOA-I Mimetic Peptides as Antiviral Therapeutic Strategy
SUMMARY: Researchers from UCLA’s Department of Medicine have developed an oral antiviral using the apoA-I mimetic peptide 4F alone or in combination with statins to prevent and treat infection of SARS-CoV-2, including long-term post-infection symptoms. ApoA-I mimetic peptides can also be given systemically as injection to attenuate viral replication...
Published: 9/5/2023   |   Inventor(s): Theodoros Kelesidis
Keywords(s):  
Category(s): Therapeutics, Therapeutics > Infectious Diseases, Therapeutics > Infectious Diseases > COVID
2014-425 A HIGH THROUGHPUT BIOCHEMICAL FLUOROMETRIC METHOD FOR MEASURING HDL REDOX ACTIVITY
SummaryUCLA researchers in the Department of Medicine have developed a method of screening for the functional properties of high-density lipoprotein (HDL) in the blood that may serve as a more accurate risk indicator of cardiovascular disease.BackgroundCardiovascular disease remains the number one cause of death for both men and women in the United...
Published: 7/19/2023   |   Inventor(s): Theodoros Kelesidis, Srinivasa Reddy, Otto Yang
Keywords(s): Cardiovascular, Diagnostic Markers & Platforms, Life Science Research Tools, Targets And Assays
Category(s): Life Science Research Tools, Diagnostic Markers, Diagnostic Markers > Targets And Assays, Therapeutics > Cardiovascular